NCT04190108 Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis. Status COMPLETED Phase N/A
NCT04163016 A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) Status COMPLETED Phase PHASE1
NCT04152759 Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04115839 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy Status TERMINATED Phase PHASE3
NCT04115748 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy Status TERMINATED Phase PHASE3
NCT04109976 A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT04108468 GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA Status COMPLETED Phase PHASE3
NCT04102449 Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast Status WITHDRAWN Phase PHASE4
NCT04062695 Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement Status UNKNOWN Phase PHASE2
NCT04018599 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS Status COMPLETED Phase PHASE1
NCT04009499 A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03986918 Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System Status UNKNOWN Phase N/A
NCT03963401 A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE2